Tech group to trumpet city's digital marketing niche

Back to TopCommentsE-mailPrintBookmark and Share

Much like Indianapolis’ declaration that it’s the “amateur sports capital of the world,” a business group has staked the claim that the city is also the “marketing technology capital of the world.”

TechPoint, which promotes Indiana’s tech industry, has honed its focus on digital marketing. The hope, according to TechPoint CEO Mike Langellier, is that Indianapolis can capitalize on the successes of some of its marketing technology firms, such as ExactTarget Inc. and Angie's List.

“A big part of it is focus. That’s why we’re changing,” Langellier said. “Let’s not just talk about tech broadly, which makes it tough to differentiate. … With this, we can distinctly say, ‘Hey, we’re not trying to be everything to everyone.’ We’re just saying we have a core competency in marketing tech.”

TechPoint, an arm of Central Indiana Corporate Partnership, plans to use a Sept. 19 marketing conference to kick start the initiative, dubbed M-Tech. Publicity material for the event notes that more than 30 marketing tech firms are headquartered in Indianapolis.

The event piggybacks onto the ExactTarget Connections marketing conference that ends the same day. The ExactTarget event drew 4,000 digital marketing professionals last year.

“As a result, we thought now is the time while we have this conference in town where we’re bringing in thousands of people, while we have all of this momentum around our marketing tech community, to put a flag in the ground and say, ‘Indy owns marketing tech.' This is going to be the marketing tech capital,” Langellier said.

Looking beyond the M-Tech launch, Langellier hinted at a wish list including a business accelerator for marketing technology companies.

So far, branding the city and marketing the new message has consumed TechPoint’s focus. One staff member works on it full time.

Everything outside of marketing needs to happen “organically,” Langellier said.

M-Tech replaces a similar but mostly dormant effort called the Indiana Measured Marketing Initiative, which launched in 2010.

Industry experts say the latest push needs to include more concrete programs—such as a business accelerator—for the initiative to succeed.

“I don’t think your competition is fierce, by any regard, but you’re sounding like a guy who declared the race won without even running yet,” said Russ Jones, chief technology officer at Virante Inc., a digital marketing firm based in Morrisville, N.C.

Jones said Indianapolis has some credibility as a digital marketing hub. So do many other cities—they just haven’t overtly declared themselves as a capital.

Indianapolis has to compete against much more established technology markets. To name a few: Silicon Valley in California, Silicon Alley in the New York area, and Research Triangle Park in North Carolina. Other mid-to-large metros such as Portland and Seattle also have gained esteem, Jones said.

However, marketing the city as a digital marketing hotbed could motivate the local industry, he said.

“It could be fluff or vaporware,” he said about the Indianapolis tech community’s declaration, “but it could drive people to become it.”

Indianapolis’ business leaders know they can’t compete with major markets like San Francisco or Boston when it comes to the overall tech sector, said Doug Karr, CEO of Indianapolis marketing consultancy DK New Media.

That is where the refined focus on digital marketing helps, said Karr, who also manages The Marketing Technology Blog.

“If someone wants to fight on who’s the best marketing tech scene, we should relish the opportunity to brag,” he said.

Bill Balderaz, who heads the Columbus, Ohio, division of Cleveland-based digital marketing consultant Fathom, could not think of another example of a city declaring itself as the capital for a niche within technology.

“There’s a lot of credit for the city to [back up] the claim,” Balderaz said about Indianapolis.

The local marketing tech sector has seen its share of recent major developments. In July, Salesforce.com closed its $2.5 billion purchase of Indianapolis-based ExactTarget, which launched a $161 million initial public offering in March 2012.

Aprimo Inc. sold to Teradata for $525 million in December 2010, and iGoDigital Holdings sold to ExactTarget for $21 million in October 2012.

Also, Indianapolis-based Angie’s List raised $114 million in an initial public offering in November 2011.

Industry research also projects that chief marketing officers will spend more on technology than chief information officers do by 2017, further fueling TechPoint’s decision to focus more on digital marketing.


  • finally! a focus!
    I know several people in the field and they are the hardest working, most fun people that you could ever meet. Attract as many of their creative and competitive minds as possible! We need them and their ability to show business leaders across the nation that Indianapolis is full of tallented professionals.
  • Not again
    The only thing Indianapolis is the capitol of is The Capitol of Declaring Ourselves Capitols of Stuff We Aren't Capitols Of. Earn it, then crow about it.
  • Love the connection with Connections
    Excited to take advantage of multiple great events in one day!
  • Cool
    Looking forward to M-TECH!
  • D.G. Roberts Needs to Buy a Clue
    Marketing technology has NOTHING to do with SPAM. Buy a vowel and get a clue before you comment on stories because you have nothing better to do than tear down people who are actually working to make Indy great!
  • Proud of my town!
    Proud to be from the spam email capital of the world! What an honor!

    Post a comment to this story

    We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
    You are legally responsible for what you post and your anonymity is not guaranteed.
    Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
    No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
    We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

    Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

    Sponsored by

    facebook - twitter on Facebook & Twitter

    Follow on TwitterFollow IBJ on Facebook:
    Follow on TwitterFollow IBJ's Tweets on these topics:
    Subscribe to IBJ
    1. So, Pence wants the federal government to ignore the 2008 law that allows children from these countries to argue for asylum in front of a judge. How did this guy become governor? And how is that we'll soon be subjected to repeatedly seeing him on TV being taken seriously as a presidential candidate? Am I in Bizzaro-U.S.A.?

    2. "And the most rigorous studies of one-year preschool programs have shown short-term benefits that fade out in a few years or no benefits at all." So we are going down a path that seems to have proven not to work very well. Right intention, wrong approach?

    3. Well for Dunkin Donuts it might say that even a highly popular outlet can't make a poorly sited location work. That little strip has seen near constant churn for years.

    4. Years ago, the Pharmaceutical and Medical Device companies shifted their research investment away from Medical Institutions to focus more on private research centers, primarily because of medical institution inefficiencies in initiating clinical studies and their inability/commitment to enroll the needed number of patients in these studies. The protracted timelines of the medical institutions were prompting significant delays in the availability of new drug and medical device entities for patients and relatedly, higher R and D expenditures to the commercial industry because of these delays. While the above stated IU Health "ratio is about $2.50 in federal funding for every $1 in industry funding", the available funding is REVERSED as commercial R and D (primarily Phase I-IV clinical work)runs $2.50 to $1 for available federal funding ($76.8B to $30.9B in 2011). The above article significatly understated the available R and D funding from industry......see the Pharma and Medical Device industry websites. Clearly, if medical institutions like IU Health wish to attract more commercial studies, they will need to become more competitive with private clinical sites in their ability to be more efficient and in their commitment to meet study enrollment goals on time. Lastly, to the reference to the above Washington Post article headlined “As drug industry’s influence over research grows, so does the potential for bias", lacks some credibility as both FDA and Institutional Institutional Review Boards must approve the high proportion of these studies before studies are started. This means that both study safety and science must be approved by both entities.

    5. ChIeF and all the other critics – better is better no matter what. Get over it; they are doing better despite you ?